维普期刊资源整合服务平台（V6.5）

233篇 您的检索式：作者名="MCLEOD HL"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Pharmacogenomics:Unlocking the human genome for better drug therapy显示文摘	McLeod HL Evans WE	2001	Ann Rev Pharmacol Toxicol2001，41，1：	1
2	Cyclo-oxygenase 2 inhibition in colorectal cancer therapy显示文摘	Church RD Fleshman JW McLeod HL	2003	British Journal of Surgery2003，90，9：	1
3	Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis 显示文摘	Ranganathan P Mcleod HL	2006	Arthritis Rheum2006，54，5：	1
4	Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity显示文摘	Wei X McLeod HL McMurrough J	1996	J Clin Invest1996，98，3：	1
5	Thymidylate synthase pharmacogenetics in colorectal cancer显示文摘	Marsh S McLeod HL	2001	Clin Colorectal Cancer2001，1，：	1
6	Pharmacogenomics: the influence of genomic variation on drug response显示文摘	Thomas FJ McLeod HL Watters JW	2004	Curr Top Med Chem2004，4，13：	1
7	Pharmacogenomics-drug disposition,drug targets,and side effects显示文摘	Evans WE McLeod HL	2003	N Engl J Med2003，348，6：	1
8	Characterization of dihydropyrimidine dehydrogenase in human colorectal tumors显示文摘	Mcleod HL Sluden J Murray GI	1998	Br J Cancer1998，77，3：	1
9	Pharmacogenetic predictors of adverse events and respones to chemotherapy in metastatic rectum cancer:results from north american gastrointestinal intergroup trial N9741 显示文摘	Mcleod HL Sargent DJ Marsh S	2010	J Clin Oncol2010，28，20：	1
10	Can dihydrophyrimidine dehyogenase impact 5-flurouracil-based treatment?显示文摘	Milano G Mcleod HL	2000	Eur J Cancer2000，36，1：	1
11	Biomarkers for response to neoadjuvant chemoradiation for rectal cancer 显示文摘	Kuremsky JC Tempper JE Mcleod HL	2009	Int J Radiat Oncol Biod Phys2009，74，3：	1
12	Pharmacogenomics:Unlocking the human genome for better drug therapy显示文摘	Mcleod HL Evans WE	2001	Ann Rev Pharmacol Toxicol2001，41，1：	1
13	Pharmacogenomics: unlocking the human genome for better drug therapy 显示文摘	Evans WE	2001	Ann Rev Pharmacol Toxicol2001，41，：	1
14	Carbamazepine, HLA-B * 1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis : US FDA recommendations 显示文摘	Ferrell PB McLeod HL	2008	Pharmacogenomics2008，9，30：	1
15	Molecular therapeutics: are we making progress ? 显示文摘	McLeod HL Watson MA	2003	Curr Opin Mol Ther2003，5，：	1
16	Carbamazepine, HLA-B * 1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis~ US FDA recommendations 显示文摘	Ferrell PB Jr McLeod HL	2008	Pharmacogenomics2008，9，：	1
17	Laser capture microscopy显示文摘	Curran S McKay JA McLeod HL	2000	Mol Pathol2000，53，2：	1
18	Thymidylate synthase pharmacogenetics in colorectal cancer显示文摘	Marsh S McLeod HL	2001	Clin Colorectal Cancer2001，1，3：	1
19	Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity显示文摘	Wei X McLeod HL McMurrough J	1996	J Clin Invest1996，98，3：	1
20	Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals显示文摘	Mcleod HL Pritchard SC Githang' a J	1999	Pharmcogenetics1999，9，6：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示